U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

Addiction drug helps kleptomaniacs, too: study

Printer-friendly version E-mail this page to a friend

Reuters Health

Tuesday, March 31, 2009

WASHINGTON (Reuters) - A drug commonly used to treat alcohol and drug addiction may help curb the urge to steal among kleptomaniacs, U.S. researchers reported on Tuesday.

They found the drug naltrexone helped take away the "thrill" that drives some kleptomaniacs to steal.

"It gets rid of that rush and desire," said Dr. Jon Grant, of the University of Minnesota, who led the study.

"The difference in their behavior was significant, and these people were really troubled by their behavior."

Writing in the Journal of Biological Psychiatry, Grant and colleagues said for two months they tested 25 patients who said they spent at least one hour a week stealing.

Those who took naltrexone reported significantly less stealing behavior compared to those given placebo.

Naltrexone is sold under the brand names Revia and Depade and is approved for use against alcohol and opiate abuse.

(Reporting by Maggie Fox; editing by Mohammad Zargham)


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: